Viridian Therapeutics Stock Momentum Indicators Percentage Price Oscillator

VRDN Stock  USD 21.87  0.04  0.18%   
Viridian Therapeutics momentum indicators tool provides the execution environment for running the Percentage Price Oscillator indicator and other technical functions against Viridian Therapeutics. Viridian Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Percentage Price Oscillator indicator function is designed to identify and follow existing trends. Momentum indicators of Viridian Therapeutics are pattern recognition functions that provide distinct formation on Viridian Therapeutics potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Fast Period, Slow Period and MA Type to execute this model.

The output start index for this execution was twenty-five with a total number of output elements of thirty-six. The Percentage Price Oscillator is a momentum indicator that describes the relationship between two Viridian Therapeutics moving averages.

Viridian Therapeutics Technical Analysis Modules

Most technical analysis of Viridian Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Viridian from various momentum indicators to cycle indicators. When you analyze Viridian charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Viridian Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Viridian Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Viridian Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Viridian Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Viridian Therapeutics's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Viridian Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Viridian Therapeutics, we also check how macroeconomic factors affect Viridian Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Dividend Yield8.52E-40.001448
Price To Sales Ratio3.1K3.3K
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Viridian Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
16.9522.4127.87
Details
Intrinsic
Valuation
LowRealHigh
21.5727.0332.49
Details
Naive
Forecast
LowNextHigh
17.0522.5027.96
Details
16 Analysts
Consensus
LowTargetHigh
39.6143.5348.32
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Viridian Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Viridian Therapeutics' short interest history, or implied volatility extrapolated from Viridian Therapeutics options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Business Services Idea
Business Services
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
Video Games Idea
Video Games
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Momentum Idea
Momentum
Invested over 60 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Power Assets Idea
Power Assets
Invested over 200 shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares
When determining whether Viridian Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Viridian Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Viridian Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Viridian Therapeutics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viridian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Viridian Stock, please use our How to Invest in Viridian Therapeutics guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viridian Therapeutics. If investors know Viridian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viridian Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.32)
Revenue Per Share
0.005
Quarterly Revenue Growth
0.194
Return On Assets
(0.32)
Return On Equity
(0.52)
The market value of Viridian Therapeutics is measured differently than its book value, which is the value of Viridian that is recorded on the company's balance sheet. Investors also form their own opinion of Viridian Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viridian Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viridian Therapeutics' market value can be influenced by many factors that don't directly affect Viridian Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viridian Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viridian Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viridian Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.